LASHONDIA ADAMS: Open Payments
NPI 1669084703 · WOBURN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 9 payments from 6 companies in 2025. Trend: 2023 $669 · 2024 $357 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $134 |
| Teva Pharmaceuticals USA, Inc. | 3 | $88 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Bausch Health US, LLC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: Auvelity, UZEDY, AUSTEDO XR, SPRAVATO, APLENZIN, REXULTI, INGREZZA.
Industry payments across MA — which companies pay providers there.
